Antibiotic Treatment for Enterobacter cloacae Complex Cystitis
Introduction to Treatment Options
- The Infectious Diseases Society of America recommends fluoroquinolones, such as ciprofloxacin 500 mg twice daily for 7 days or levofloxacin 750 mg once daily for 5 days, for the treatment of Enterobacter cloacae complex cystitis, given the organism's documented susceptibility to these agents 1, 2
- Fluoroquinolones are highly efficacious for urinary tract infections and achieve excellent urinary concentrations, making them ideal for this clinical scenario where the organism demonstrates full susceptibility 1, 2
Alternative Treatment Options
- Trimethoprim-Sulfamethoxazole (160/800 mg twice daily for 3 days) is an appropriate alternative given documented susceptibility (MIC ≤20, sensitive) 1, 2
- Cefepime shows susceptibility (MIC ≤0.12) and is a fourth-generation cephalosporin that maintains activity against AmpC-producing organisms, but oral formulations are not widely available 4, 5
- Tobramycin shows susceptibility (MIC ≤1), and single-dose aminoglycoside therapy is recommended for simple cystitis due to resistant organisms 6, 4, 5
Critical Considerations
- Verify estimated glomerular filtration rate (eGFR) before prescribing any antibiotic, as renal function may be impaired in elderly patients 7
- If eGFR <30 mL/min, avoid nitrofurantoin and adjust fluoroquinolone dosing accordingly 7
- Carbapenems (ertapenem MIC ≤0.12, meropenem MIC ≤0.25) are reserved for severe infections and should not be used for uncomplicated cystitis due to antimicrobial stewardship principles 4, 5